1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Ankylosing Spondylitis (Bekhterev%s Disease)-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Ankylosing Spondylitis (Bekhterev's Disease)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Ankylosing Spondylitis (Bekhterev's Disease). This report provides information on the therapeutic development based on the Ankylosing Spondylitis (Bekhterev's Disease) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterev's Disease)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Ankylosing Spondylitis (Bekhterev's Disease) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Ankylosing Spondylitis (Bekhterev's Disease)
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterev's Disease) pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Ankylosing Spondylitis (Bekhterev%s Disease)-Pipeline Insights, 2014
Table of Contents
- Ankylosing Spondylitis (Bekhterev's Disease) Overview
- Ankylosing Spondylitis (Bekhterev's Disease) Pipeline Therapeutics
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics under Development by Companies
- Ankylosing Spondylitis (Bekhterev's Disease) Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Ankylosing Spondylitis (Bekhterev's Disease) Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Ankylosing Spondylitis (Bekhterev's Disease) Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Ankylosing Spondylitis (Bekhterev's Disease) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Ankylosing Spondylitis (Bekhterev's Disease) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Ankylosing Spondylitis (Bekhterev's Disease) - Discontinued Products
- Ankylosing Spondylitis (Bekhterev's Disease) - Dormant Products
- Companies Involved in Therapeutics Development for Ankylosing Spondylitis (Bekhterev's Disease)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Monotherapy Products
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Combination Products
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Route of Administration
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Stage and Route of Administration
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Molecule Type
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Stage and Molecule Type
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics - Discontinued Products
- Ankylosing Spondylitis (Bekhterev's Disease) Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Ankylosing Spondylitis (Bekhterev's Disease), 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Monotherapy Products
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Combination Products
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Route of Administration
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Stage and Route of Administration
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Molecule Type
- Ankylosing Spondylitis (Bekhterev's Disease) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

Phototherapy Equipment Market by Type, Application, End-user, Geography - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge ...

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

Antinuclear Antibody Test Market by Product, Technique, Disease, End User - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global antinuclear antibody (ANA) testing market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016, at a CAGR of 12.4%. The global ANA testing market is segmented based ...

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

Interstitial Cystitis  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Pathology Statistics in France

  • November 2016
    2 pages
  • Pathology  

  • France  

    Europe  

    United States  

View report >

Influenza Statistics in the US

  • November 2016
    7 pages
  • Influenza  

    Influenza Vacci...  

    Vaccine  

  • United States  

View report >

Related Market Segments :

Autoimmune Disease

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.